WORTH Paths: digital support for women with substance use and contraception needs
Official title: Adaptation of a Digital Group-Based Intervention to Reduce Drug Use and Increase Contraceptive Use Among Reproductive-Aged Women Involved in Criminal Justice Systems
Run by Fairleigh Dickinson University · NCT06889831 · Data updated 2026-11-12
This study tests whether WORTH Paths, a brief digital group program, can help reproductive-aged women involved in the criminal legal system reduce drug use and increase use of contraception.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 44 Years |
| Sex | Women only |
| Enrollment | 50 (estimated) |
| Sponsor | Fairleigh Dickinson University Academic / other |
| Locations | 1 site (Teaneck, New Jersey) |
| Status | Recruiting |
| Started | August 12, 2025 |
| Main results expected | September 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT06889831 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking individuals assigned female at birth, aged 18–44, with past-year criminal legal involvement, a current DSM-5 substance use disorder, sexually active with an unmet need for contraception, and able to provide informed consent.
✕Probably not a fit
People who are currently pregnant or trying to conceive, have diagnosed infertility, cannot provide informed consent, or are unable or unwilling to attend virtual sessions are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
WORTH Paths is a digital adaptation of the evidence-based WORTH intervention, expanded to address a full range of contraceptive options alongside strategies to reduce substance use. In a randomized design, 50 participants will be assigned to the WORTH Paths intervention (three facilitated virtual group sessions) or an active wellness group, with feasibility, acceptability, and preliminary behavioral outcomes tracked over follow-up. Eligibility focuses on English-speaking people assigned female at birth, ages 18–44, with past-year criminal legal involvement, current DSM-5 substance use disorder, and an unmet need for contraception. The study measures changes in drug use and contraceptive uptake as well as participant engagement and satisfaction.
Why it matters
Potential benefit: If successful, the program could increase contraceptive use and reduce drug use by offering accessible, tailored digital group support for justice-involved women.
How similar studies have gone: The original WORTH intervention has demonstrated success increasing condom use, but this digital adaptation targeting broader contraceptive uptake plus substance use reduction is a novel approach with limited prior testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female sex at birth * Aged 18-44 years * Past year criminal legal involvement (e.g., incarceration or community supervision) * Meets criteria for current substance use disorder (SUD) as defined by DSM-5 and assessed by the Mini-International Neuropsychiatric Interview (MINI) * Meets criteria for unmet need for contraception (capable of pregnancy, sexually active, does not want to become pregnant within the next year, but is currently not using contraception) * Able to read, write, and speak English * Willing and able to provide informed consent Exclusion Criteria: * Currently pregnant or actively trying to conceive * Diagnosed infertility (e.g., menopause, tubal ligation, hysterectomy) * Unable to provide informed consent due to significant cognitive impairment, mental health condition, or substance intoxication * Unable or unwilling to meet study requirements (e.g., attend sessions, complete assessments)
Where it's running
-
Fairleigh Dickinson University
Teaneck, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Melissa N Slavin, PhD — Fairleigh Dickinson University
- Study coordinator: Melissa N Slavin, PhD
- Email: m.slavin@fdu.edu
- Phone: 201-692-2301
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
Intelligent Sexual Health Help System for Gynecologic Cancer Patients
A smartphone-based sexual health education and consultation system called LillyBot will be tested with gynecologic cancer patients to see if it improves sexual well-being.
-
Afrocentric Sexual and Reproductive Health Curriculum for Health Professionals in Tanzania
This study tests whether a four-day Afrocentric curriculum for medical, nursing, and midwifery students in Tanzania improves their sexual health knowledge, attitudes, and counseling skills.
-
Real-time fMRI Neurofeedback for Anhedonia in Methadone-Treated Opioid Use Disorder
This feasibility study tests a real-time fMRI neurofeedback approach to see if it helps reduce anhedonia in people on methadone for opioid use disorder.
-
Trauma recovery options for veterans: comparing HRV biofeedback and present-centered therapy
This trial tests whether Heart Rate Variability Biofeedback plus trauma-informed care helps veterans with PTSD and substance use issues more than present-centered therapy.
-
Mobile health approach to support first-year Ethiopian female students’ sexual health, nutrition, and wellbeing
A mobile health program will test whether monthly app-based education can improve sexual and reproductive health, nutrition, and psychosocial wellbeing among first-year female university students in Ethiopia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.